EXABS-100-AML Is TP53 Mutated AML the Same Disease as TP53 Mutated MDS?

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	S3-S5
Journal	Clinical Lymphoma, Myeloma and Leukemia
Volume	22
DOIs	https://doi.org/10.1016/S2152-2650(22)00640-1
Publication status	Published - Oct 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{1b1c5359282e4cdeb41503a8883ed662,

title = "EXABS-100-AML Is TP53 Mutated AML the Same Disease as TP53 Mutated MDS?",

author = "Valk, {Peter J.M.}",

year = "2022",

month = oct,

doi = "10.1016/S2152-2650(22)00640-1",

language = "English",

volume = "22",

pages = "S3--S5",

journal = "Clinical Lymphoma, Myeloma and Leukemia",